» Articles » PMID: 36149768

Interleukin 4/13 Signaling in Cardiac Regeneration and Repair

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin 4 (IL4) and interleukin 13 (IL13) are closely related cytokines that have been classically attributed to type II immunity, namely, differentiation of T-helper 2 (T2) cells and alternative activation of macrophages. Although the role of IL4/13 has been well described in various contexts such as defense against helminth parasites, pathogenesis of allergic disease, and several models of wound healing, relatively little is known about the role of IL4/13 in the heart following injury. Emerging literature has identified various roles for IL4/13 in animal models of cardiac regeneration as well as in the adult mammalian heart following myocardial injury. Notably, although IL4 and IL13 signal to hematopoietic cell types following myocardial infarction (MI) to promote wound healing phenotypes, there is substantial evidence that these cytokines can signal directly to non-hematopoietic cell types in the heart during development, homeostasis, and following injury. Comprehensive understanding of the molecular and cellular actions of IL4/13 in the heart is still lacking, but overall evidence to date suggests that activation of these cytokines results in beneficial outcomes with respect to cardiac repair. Here, we aim to comprehensively review the role of IL4 and IL13 and their prospective mechanisms in cardiac regeneration and repair.

Citing Articles

Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts.

Cazzola M, Calzetta L, Rogliani P, Matera M Int J Chron Obstruct Pulmon Dis. 2024; 19:2481-2495.

PMID: 39606712 PMC: 11600434. DOI: 10.2147/COPD.S498255.


Group 2 innate lymphocytes protect the balance between autophagy and apoptosis in cardiomyocytes during sepsis-induced cardiac injury.

Fang K, Chen H, Xie J, Sun D, Li L Sci Rep. 2024; 14(1):25011.

PMID: 39443633 PMC: 11500105. DOI: 10.1038/s41598-024-76606-4.


IL-4 attenuates myocardial infarction injury by promoting M2 macrophage polarization.

Lu D, Fan J, Lin Y, Yang K, Zheng F, Ma T Ann Med Surg (Lond). 2024; 86(6):3349-3356.

PMID: 38846847 PMC: 11152837. DOI: 10.1097/MS9.0000000000002044.


Global IL4Rα blockade exacerbates heart failure after an ischemic event in mice and humans.

Alvarez-Argote S, Almeida V, Knas M, Buday S, Patterson M, OMeara C Am J Physiol Heart Circ Physiol. 2024; 326(5):H1080-H1093.

PMID: 38426866 PMC: 11380969. DOI: 10.1152/ajpheart.00010.2024.


IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophages.

Alvarez-Argote S, Paddock S, Flinn M, Moreno C, Knas M, Almeida V JCI Insight. 2023; 9(2).

PMID: 38051583 PMC: 10906228. DOI: 10.1172/jci.insight.172702.


References
1.
Akaiwa M, Yu B, Terada N, Suto H, Koga T, Arima K . Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine. 2001; 13(2):75-84. DOI: 10.1006/cyto.2000.0814. View

2.
Nahrendorf M . Myeloid cells in cardiovascular organs. J Intern Med. 2018; 285(5):491-502. PMC: 6497541. DOI: 10.1111/joim.12844. View

3.
Kellner J, Gamarra F, Welsch U, Jorres R, Huber R, Bergner A . IL-13Ralpha2 reverses the effects of IL-13 and IL-4 on bronchial reactivity and acetylcholine-induced Ca+ signaling. Int Arch Allergy Immunol. 2006; 142(3):199-210. DOI: 10.1159/000097022. View

4.
Jankovic D, Liu Z, Gause W . Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 2001; 22(8):450-7. DOI: 10.1016/s1471-4906(01)01975-5. View

5.
Okamoto H, Yoshimatsu Y, Tomizawa T, Kunita A, Takayama R, Morikawa T . Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma. Sci Rep. 2019; 9(1):1281. PMC: 6362032. DOI: 10.1038/s41598-019-39018-3. View